CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer's disease.
Alzheimers Res Ther
; 14(1): 198, 2022 12 29.
Article
in En
| MEDLINE
| ID: mdl-36581878
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Alzheimer Disease
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Alzheimers Res Ther
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: